Hornung Annkathrin, Poettler Marina, Friedrich Ralf P, Zaloga Jan, Unterweger Harald, Lyer Stefan, Nowak Johannes, Odenbach Stefan, Alexiou Christoph, Janko Christina
Department of Otorhinolaryngology, Head and Neck Surgery, Section for Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung Professorship, University Hospital Erlangen, Glückstraße 10a, 91054 Erlangen, Germany.
Friedrich-Alexander-University Erlangen-Nuremberg (FAU), 91054 Erlangen, Germany.
Molecules. 2015 Sep 30;20(10):18016-30. doi: 10.3390/molecules201018016.
Major problems of cancer treatment using systemic chemotherapy are severe side effects. Magnetic drug targeting (MDT) employing superparamagnetic iron oxide nanoparticles (SPION) loaded with chemotherapeutic agents may overcome this dilemma by increasing drug accumulation in the tumor and reducing toxic side effects in the healthy tissue. For translation of nanomedicine from bench to bedside, nanoparticle-mediated effects have to be studied carefully. In this study, we compare the effect of SPION, unloaded or loaded with the cytotoxic drug mitoxantrone (MTO) with the effect of free MTO, on the viability and proliferation of HT-29 cells within three-dimensional multicellular tumor spheroids. Fluorescence microscopy and flow cytometry showed that both free MTO, as well as SPION-loaded MTO (SPION(MTO)) are able to penetrate into tumor spheroids and thereby kill tumor cells, whereas unloaded SPION did not affect cellular viability. Since SPION(MTO) has herewith proven its effectivity also in complex multicellular tumor structures with its surrounding microenvironment, we conclude that it is a promising candidate for further use in magnetic drug targeting in vivo.
使用全身化疗进行癌症治疗的主要问题是严重的副作用。采用负载化疗药物的超顺磁性氧化铁纳米颗粒(SPION)的磁性药物靶向(MDT),可以通过增加肿瘤中的药物积累和减少健康组织中的毒副作用来克服这一困境。为了将纳米医学从实验室转化到临床应用,必须仔细研究纳米颗粒介导的效应。在本研究中,我们比较了未负载或负载细胞毒性药物米托蒽醌(MTO)的SPION与游离MTO对三维多细胞肿瘤球体中HT-29细胞活力和增殖的影响。荧光显微镜和流式细胞术显示,游离MTO以及负载SPION的MTO(SPION(MTO))都能够穿透肿瘤球体,从而杀死肿瘤细胞,而未负载的SPION不影响细胞活力。由于SPION(MTO)在具有周围微环境的复杂多细胞肿瘤结构中也已证明其有效性,我们得出结论,它是体内磁性药物靶向进一步应用的有前途的候选者。